Beneficient (NASDAQ:BENF) Stock Price Down 7.5%

Beneficient (NASDAQ:BENF - Get Free Report) fell 7.5% during trading on Friday . The company traded as low as $4.17 and last traded at $4.21. 19,867 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 96,049 shares. The stock had previously closed at $4.55.

Beneficient Stock Down 13.8 %

The firm has a fifty day simple moving average of $9.33 and a 200-day simple moving average of $34.43.

Beneficient (NASDAQ:BENF - Get Free Report) last issued its quarterly earnings results on Tuesday, February 13th. The company reported ($156.00) EPS for the quarter. The company had revenue of ($10.24) million during the quarter.

Insider Activity

In other news, Director Peter T. Cangany, Jr. bought 2,500 shares of the stock in a transaction dated Tuesday, February 20th. The shares were bought at an average price of $20.80 per share, for a total transaction of $52,000.00. Following the completion of the purchase, the director now owns 2,500 shares in the company, valued at $52,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 8.36% of the company's stock.


Hedge Funds Weigh In On Beneficient

A number of large investors have recently made changes to their positions in the company. Citadel Advisors LLC bought a new position in Beneficient during the 2nd quarter worth $35,000. Tower Research Capital LLC TRC acquired a new position in Beneficient during the 2nd quarter worth about $55,000. State Street Corp acquired a new position in Beneficient during the 2nd quarter worth about $83,000. Bank of New York Mellon Corp acquired a new position in Beneficient during the 3rd quarter worth about $98,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in shares of Beneficient in the 3rd quarter valued at about $98,000. Institutional investors own 90.57% of the company's stock.

Beneficient Company Profile

(Get Free Report)

Beneficient, a technology-enabled financial service company, provides liquidity solutions and related trust, custody and administrative services to participants in the alternative asset industry. The company operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. It offers AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks and complete their transactions with standardized transaction agreements.

Read More

→ The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Beneficient right now?

Before you consider Beneficient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beneficient wasn't on the list.

While Beneficient currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: